Valor202020212022202320242025TTMGastos comerciales, generales y administrativos3.18 B3.32 B2.76 B2.84 B2.93 B3.26 B3.26 BInvestigación y desarrollo372 M497.2 M406 M458.7 M437.4 M458.5 M458.5 MBeneficio operativo-87.8 M780.1 M696.3 M1.28 B1.29 B1.1 B1.1 BTotal de ingresos no operativos2.6 M8.1 M-239.3 M-28.4 M-57.2 M26 M11.3 MGastos por intereses, netos de intereses capitalizados———————Ingresos no operativos, una vez deducidos los gastos por intereses-22.8 M-3.7 M-111.3 M-19.1 M-26.1 M500 K-14.2 MIngresos/gastos extraordinarios25.4 M11.8 M-128 M-9.3 M-31.1 M25.5 M25.5 MBeneficio antes de impuestos-274.4 M418.4 M403.5 M1.07 B1.04 B830.8 M830.8 MParticipación en los beneficios———————Impuestos-137 M16.3 M112.3 M42.2 M131.4 M125.7 M125.7 MParticipación minoritaria1.5 M500 K—————Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas-138.9 M401.6 M290.2 M1.08 B962.6 M705.1 M705.1 MOperaciones suspendidas——-58.8 M-58.8 M-58.8 M——Beneficio neto-138.9 M401.6 M231.4 M1.02 B903.8 M705.1 M705.1 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-138.9 M401.6 M231.4 M1.02 B903.8 M705.1 M705.1 MBeneficio básico por acción-0.671.931.14.914.453.563.56Beneficio por acción diluido-0.671.911.14.884.433.553.55Número medio de acciones ordinarias207 M208.6 M209.6 M208.7 M203.1 M198 M792.9 MAcciones diluidas207 M210.4 M210.3 M209.7 M203.9 M198.7 M795.5 MEBITDA732.9 M1.64 B1.46 B2.03 B2.06 B1.9 B1.9 BEBIT-299.8 M571.7 M531.5 M1.08 B1.07 B805.3 M805.3 MCosto de los ingresos2.13 B2.34 B2.02 B2.08 B2.19 B2.49 B2.49 BOtros costes de producción250 M181.7 M137.3 M155.2 M149.9 M311.2 M—Amortización y depreciación (flujo de caja)1.03 B1.07 B926.4 M951.7 M996.3 M1.09 B1.09 B
Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
In 2001, Zimmer was spun off from Bristol Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet.
On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook.